VanEck Pharmaceutical ETF
PPH
PPH
75 hedge funds and large institutions have $70.5M invested in VanEck Pharmaceutical ETF in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.46% more ownership
Funds ownership: 16.76% → 19.22% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
63% less call options, than puts
Call options by funds: $335K | Put options by funds: $909K
Holders
75
Holding in Top 10
1
Calls
$335K
Puts
$909K
Top Buyers
| 1 | +$7.09M | |
| 2 | +$3M | |
| 3 | +$1.86M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$708K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$557K |
Top Sellers
| 1 | -$2.8M | |
| 2 | -$1.87M | |
| 3 | -$1.51M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$979K |
| 5 |
WI
Wintrust Investments
Chicago,
Illinois
|
-$882K |